Leadership changes
Executive appointments and departures from SEC 8-K filings, updated within hours of each filing.
Updated Nov 6, 2026
Changes, November 2026
297
Appointments
156
Departures
26
Browse by role
Get new CFO appointments the day the filing lands.
Browse by month
Filters
3,409 changes
| Filing date | Company | Person | Role | Change | Effective date | Source |
|---|---|---|---|---|---|---|
| Sep 28, 2026 | Asana, Inc. | Dan Rogers | Chair of the BoardChair of the Board | Appointed | Sep 25, 2026 | SEC 8-K |
| Sep 28, 2026 | Asana, Inc. | Tom Berquist | Class II directorClass II director | Appointed | Sep 25, 2026 | SEC 8-K |
| Sep 28, 2026 | Asana, Inc. | Jerry Ting | Class I directorClass I director | Appointed | Sep 25, 2026 | SEC 8-K |
| Sep 28, 2026 | Asana, Inc. | Heather Le | Chief Accounting Officer and Principal Accounting OfficerChief Accounting Officer and Principal Accounting Officer | Appointed | Sep 25, 2026 | SEC 8-K |
| Sep 28, 2026 | BIOTRICITY INC. | Jainal Bhuiyan | member of the Board and as a member of the Compensation Committee of the Boardmember of the Board and as a member of the Compensation Committee of the Board | Departed | Sep 22, 2026 | SEC 8-K |
| Sep 28, 2026 | BIOTRICITY INC. | Ronald McClurg | Compensation CommitteeCompensation Committee | Appointed | n/a | SEC 8-K |
| Sep 28, 2026 | Cambium Networks Corp | Morgan Kurk | member of the Board of Directorsmember of the Board of Directors | Departed | Sep 24, 2026 | SEC 8-K |
| Sep 28, 2026 | Celularity Inc | Geoffrey Ling, M.D., Ph.D. | directordirector | Departed | Sep 24, 2026 | SEC 8-K |
| Sep 28, 2026 | Celularity Inc | Philip A. Barach | directordirector | Appointed | Sep 24, 2026 | SEC 8-K |
| Sep 28, 2026 | CORE MOLDING TECHNOLOGIES INC | Michael J. Gayford | Chief Operating Officer (“COO”)COO | Appointed | Sep 28, 2026 | SEC 8-K |
| Sep 28, 2026 | Emmis Acquisition Corp. | Kenneth C. Greenberg | Class II directorClass II director | Appointed | Sep 25, 2026 | SEC 8-K |
| Sep 28, 2026 | F&M BANK CORP | Michael W. Pugh | DirectorDirector | Departed | Sep 24, 2026 | SEC 8-K |
| Sep 28, 2026 | FULLER H B CO | Ruth S. Kimmelshue | member of the Board of Directorsmember of the Board of Directors | Departed | Sep 23, 2026 | SEC 8-K |
| Sep 28, 2026 | FULLER H B CO | R. Jeffrey Bailly | Class I directorClass I director | Appointed | Sep 23, 2026 | SEC 8-K |
| Sep 28, 2026 | Gain Therapeutics, Inc. | Gianluca Fuggetta | Senior Vice President of Finance, principal financial officer, and principal accounting officerCFO | Departed | Sep 30, 2026 | SEC 8-K |
| Sep 28, 2026 | Gain Therapeutics, Inc. | Gene Mack | interim Chief Financial OfficerCFO | Appointed | Oct 1, 2026 | SEC 8-K |
| Sep 28, 2026 | GRAPHIC PACKAGING HOLDING CO | Aditya J. Gandhi | Vice President and Chief Accounting OfficerVice President and Chief Accounting Officer | Appointed | Sep 28, 2026 | SEC 8-K |
| Sep 28, 2026 | HAIN CELESTIAL GROUP INC | Michael J. Ragusa | Senior Vice President, Chief Accounting Officer and principal accounting officerSenior Vice President, Chief Accounting Officer and principal accounting officer | Departed | Nov 1, 2026 | SEC 8-K |
| Sep 28, 2026 | Humacyte, Inc. | Scott Coward | Class I directorClass I director | Appointed | Sep 22, 2026 | SEC 8-K |
| Sep 28, 2026 | Humacyte, Inc. | Paul Kuznik | Class II directorClass II director | Appointed | Sep 22, 2026 | SEC 8-K |
- Asana, Inc.Appointed
Dan Rogers Chair of the Board
Filed Sep 28, 2026Effective Sep 25, 2026SEC 8-K
- Asana, Inc.Appointed
Tom Berquist Class II director
Filed Sep 28, 2026Effective Sep 25, 2026SEC 8-K
- Asana, Inc.Appointed
Jerry Ting Class I director
Filed Sep 28, 2026Effective Sep 25, 2026SEC 8-K
- Asana, Inc.Appointed
Heather Le Chief Accounting Officer and Principal Accounting Officer
Filed Sep 28, 2026Effective Sep 25, 2026SEC 8-K
- BIOTRICITY INC.Departed
Jainal Bhuiyan member of the Board and as a member of the Compensation Committee of the Board
Filed Sep 28, 2026Effective Sep 22, 2026SEC 8-K
- BIOTRICITY INC.Appointed
Ronald McClurg Compensation Committee
Filed Sep 28, 2026SEC 8-K
- Cambium Networks CorpDeparted
Morgan Kurk member of the Board of Directors
Filed Sep 28, 2026Effective Sep 24, 2026SEC 8-K
- Celularity IncDeparted
Geoffrey Ling, M.D., Ph.D. director
Filed Sep 28, 2026Effective Sep 24, 2026SEC 8-K
- Celularity IncAppointed
Philip A. Barach director
Filed Sep 28, 2026Effective Sep 24, 2026SEC 8-K
- CORE MOLDING TECHNOLOGIES INCAppointed
Michael J. Gayford COO
Filed Sep 28, 2026Effective Sep 28, 2026SEC 8-K
- Emmis Acquisition Corp.Appointed
Kenneth C. Greenberg Class II director
Filed Sep 28, 2026Effective Sep 25, 2026SEC 8-K
- F&M BANK CORPDeparted
Michael W. Pugh Director
Filed Sep 28, 2026Effective Sep 24, 2026SEC 8-K
- FULLER H B CODeparted
Ruth S. Kimmelshue member of the Board of Directors
Filed Sep 28, 2026Effective Sep 23, 2026SEC 8-K
- FULLER H B COAppointed
R. Jeffrey Bailly Class I director
Filed Sep 28, 2026Effective Sep 23, 2026SEC 8-K
- Gain Therapeutics, Inc.Departed
Gianluca Fuggetta CFO
Filed Sep 28, 2026Effective Sep 30, 2026SEC 8-K
- Gain Therapeutics, Inc.Appointed
Gene Mack CFO
Filed Sep 28, 2026Effective Oct 1, 2026SEC 8-K
- GRAPHIC PACKAGING HOLDING COAppointed
Aditya J. Gandhi Vice President and Chief Accounting Officer
Filed Sep 28, 2026Effective Sep 28, 2026SEC 8-K
- HAIN CELESTIAL GROUP INCDeparted
Michael J. Ragusa Senior Vice President, Chief Accounting Officer and principal accounting officer
Filed Sep 28, 2026Effective Nov 1, 2026SEC 8-K
- Humacyte, Inc.Appointed
Scott Coward Class I director
Filed Sep 28, 2026Effective Sep 22, 2026SEC 8-K
- Humacyte, Inc.Appointed
Paul Kuznik Class II director
Filed Sep 28, 2026Effective Sep 22, 2026SEC 8-K